Thrombophilia Super Maxi Test

Thrombophilia Super Maxi Test is a comprehensive blood test designed to assess an individual's risk of developing blood clots (thrombosis). It analyzes various factors that can contribute to clotting abnormalities, providing valuable information for diagnosis, management, and prevention of thrombotic events. It detects:

• Protein C, Protein S, and Antithrombin-III: These are naturally occurring anticoagulant proteins that inhibit blood clotting. Deficiencies in these proteins can increase the risk of thrombosis
• Activated Protein C Resistance (APCR): This test identifies a specific mutation in the Factor V Leiden gene, which can make an individual more resistant to the anticoagulant effect of activated Protein C, increasing thrombosis risk
• Lupus Anticoagulant and Anti-β2 Glycoprotein Antibodies: These are antiphospholipid antibodies that can interfere with normal blood clotting, leading to thrombosis or miscarriage
• Anticardiolipin Antibodies (IgM/IgG): Similar to Lupus Anticoagulant, these antibodies can also contribute to thrombosis and pregnancy complications.
• Homocysteine: Elevated levels of homocysteine, an amino acid, can damage blood vessel walls and increase thrombosis risk
• Factor VIII Activity: This test measures the activity of Factor VIII, a clotting factor. Abnormalities in Factor VIII activity can be associated with increased or decreased bleeding risk
• Factor V Leiden G1691A Mutation: To identify individuals with a genetic mutation increasing their blood clot risk